Loading...

Steven Pennybaker, MD

Title(s)Resident, Psychiatry
SchoolSchool of Medicine
vCardDownload vCard
    Other Positions
    Title(s)UCSF Weill Institute for Neurosciences


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Saleemi S, Pennybaker SJ, Wooldridge M, Johnson MW. Who is 'Molly'? MDMA adulterants by product name and the impact of harm-reduction services at raves. J Psychopharmacol. 2017 08; 31(8):1056-1060. PMID: 28693371.
      View in: PubMed
    2. Kevin Yu, Lawrence Park, David Luckenbaugh, Steven Pennybaker, Matthew Hopkins, Marc Lener, Carlos Zarate. 517 Effects of Ketamine on Atypical and Typical Symptoms of Depression. Biological Psychiatry. 2017 May 1; 81(10):s210.
      View in: Publisher Site
    3. Pennybaker SJ, Luckenbaugh DA, Park LT, Marquardt CA, Zarate CA. Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion. Biol Psychiatry. 2017 09 01; 82(5):e35-e36. PMID: 28262250.
      View in: PubMed
    4. Pennybaker SJ, Niciu MJ, Luckenbaugh DA, Zarate CA. Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion. J Affect Disord. 2017 Jan 15; 208:560-566. PMID: 27839782.
      View in: PubMed
    5. Pennybaker S, Hemming P, Roy D, Anton B, Chisolm MS. Risks, Benefits, and Recommendations for Pastoral Care on Inpatient Psychiatric Units: A Systematic Review. J Psychiatr Pract. 2016 09; 22(5):363-81. PMID: 27648501.
      View in: PubMed